OOIR: Observatory of International Research

Papers

(The H4-Index of Thorax is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Vaping and CBD: can new technology overcome old problems?	187
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	142
Journal club	122
E-cigarette use in young adults and adolescents: not so safe?	121
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	115
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	115
Beware, vaping e-cigarettes around children is adversely impacting their lung health	95
Ablation for lung cancer: hot or cold intervention	86
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	75
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	69
Correction:British Thoracic Society Winter Meeting 2023	67
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	66
Lung development genes, adult lung function and cardiovascular comorbidities	66
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	65
Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial	63
Complex coexistence of COPD and cardiovascular disease	62
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	61
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	60
British Thoracic Society Guideline for pleural disease	56
Correction:RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock	55
Highlights from this issue	50
Lower airway microbiota in COPD and healthy controls	49
Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis	49
Muscle memory: genetic factors underlying functional impairment in COPD	46
Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark	45

Ageing and ivacaftor: unravelling the long-term effects	45
Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review	45
Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study	44
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care	44
BTS Clinical Statement on air travel for passengers with respiratory disease	43
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	42
Toxic metals and lung health: silent poisons?	41
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis	40
Prevalence of lung cysts in adolescents and adults with a germlineDICER1pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary B	39
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	39
Activation of epithelial and inflammatory pathways in adolescent elite athletes exposed to intense exercise and air pollution	39
Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study	39
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease	38